[go: up one dir, main page]

MX2010005175A - Comprimido dispersable oral. - Google Patents

Comprimido dispersable oral.

Info

Publication number
MX2010005175A
MX2010005175A MX2010005175A MX2010005175A MX2010005175A MX 2010005175 A MX2010005175 A MX 2010005175A MX 2010005175 A MX2010005175 A MX 2010005175A MX 2010005175 A MX2010005175 A MX 2010005175A MX 2010005175 A MX2010005175 A MX 2010005175A
Authority
MX
Mexico
Prior art keywords
tablet
oral
dispersable tablet
oral dispersable
amount
Prior art date
Application number
MX2010005175A
Other languages
English (en)
Inventor
Tobias Laich
Thomas Steenpass
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of MX2010005175A publication Critical patent/MX2010005175A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a un comprimido disgregable oral que presenta una capacidad de disgregación oral de no más de 60 segundos. El comprimido para administración oral, comprende una cantidad eficaz de al menos un agente activo, una cantidad de al menos el 50% (p/p) de partes insolubles en agua, un tensioactivo y un disgregante, de manera que dicho comprimido puede disgregarse o dispersarse por vía oral.
MX2010005175A 2007-12-08 2008-11-25 Comprimido dispersable oral. MX2010005175A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07023802 2007-12-08
PCT/EP2008/009968 WO2009071219A2 (en) 2007-12-08 2008-11-25 Oral dispersable tablet

Publications (1)

Publication Number Publication Date
MX2010005175A true MX2010005175A (es) 2010-08-02

Family

ID=40631079

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005175A MX2010005175A (es) 2007-12-08 2008-11-25 Comprimido dispersable oral.

Country Status (9)

Country Link
EP (1) EP2231126A2 (es)
JP (2) JP2011506279A (es)
KR (1) KR20100096140A (es)
CN (1) CN101888834A (es)
BR (1) BRPI0820861A2 (es)
MX (1) MX2010005175A (es)
RU (1) RU2010128019A (es)
TW (1) TW200938233A (es)
WO (1) WO2009071219A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2476423A4 (en) * 2009-09-08 2014-02-19 Kyowa Chem Ind Co Ltd TABLET ANTIACIDE AND LAXATIVE
CN101797236B (zh) * 2010-03-23 2012-05-23 西南大学 重酒石酸卡巴拉汀口腔崩解片及其制备方法
AU2011247642C1 (en) * 2010-04-27 2015-11-12 Bayer Intellectual Property Gmbh Orally disintegrating tablet containing acarbose
US20110300216A1 (en) * 2010-06-03 2011-12-08 First Eric R Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
JP5750856B2 (ja) * 2010-10-04 2015-07-22 ライオン株式会社 固形医薬組成物及び医薬製剤
KR101237646B1 (ko) * 2010-12-09 2013-03-04 주식회사 드림파마 생체이용률이 개선된 셀레콕시브 함유 고체 분산체, 이를 포함하는 약학 조성물 및 이의 제조방법
FR2968995B1 (fr) * 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
FR2968992B1 (fr) * 2010-12-16 2013-02-08 Sanofi Aventis Comprime pharmaceutique orodispersible a base de zolpidem
TR201100150A2 (tr) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Suda çözünür dozaj formları
WO2013115741A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic Pharmaceutical compositions comprising alpha-glucosidase inhibitor
CN102600149B (zh) * 2012-02-02 2013-12-04 西藏易明西雅生物医药科技有限公司 一种治疗糖尿病的药物组合物
US20160136091A1 (en) 2013-07-19 2016-05-19 Sanwa Kagaku Kenkyusho Co., Ltd. Orally Disintegrating Tablet
EP3021837A1 (en) * 2013-07-19 2016-05-25 Bayer Pharma Aktiengesellschaft Super quick disintegrating tablet formula for api miglitol
CN103877041B (zh) * 2014-03-14 2016-07-06 崔书豪 一种吡罗昔康分散片及其制备方法
CA3048952A1 (en) 2016-01-29 2017-08-03 Hikaru Kobayashi Solid preparation, method for producing solid preparation, and method for generating hydrogen
CN105640954B (zh) * 2016-02-04 2019-03-05 青岛市海慈医疗集团 一种治疗消化不良的西沙必利片剂
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2018010543A1 (zh) * 2016-07-11 2018-01-18 武汉朗来科技发展有限公司 一种用于口服固体制剂的复合崩解剂体系及含有该复合崩解剂体系的口服固体制剂
WO2018037819A1 (ja) 2016-08-23 2018-03-01 小林　光 配合物及びその製造方法、並びに水素供給方法
CN110191699A (zh) 2016-08-23 2019-08-30 小林光 氢供给材料与其制造方法、及氢供给方法
CN107334742B (zh) * 2017-08-18 2020-01-31 山东力诺制药有限公司 一种盐酸氟西汀分散片及其制备方法
EP3648745B1 (en) * 2017-09-28 2024-06-26 Hanmi Pharm. Co., Ltd. Pharmaceutical composition including multi-unit spheroidal tablet containing esomeprazole and spheroidal pharmaceutically acceptable salt thereof, and method of preparing the pharmaceutical composition
CN110840850B (zh) * 2018-07-24 2023-03-17 烟台药物研究所 一种高生物利用度的塞来昔布冻干口崩片及其制备方法
CN109864971B (zh) * 2019-04-08 2021-12-17 西安远大德天药业股份有限公司 一种拉莫三嗪固体分散体的颗粒剂及其制备方法
CN114224855B (zh) * 2021-12-01 2023-11-28 北京悦康科创医药科技股份有限公司 一种甲磺酸多沙唑嗪口含片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802700A1 (de) * 1998-01-24 1999-07-29 Bayer Ag Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält
EP1469829B1 (en) * 2002-02-01 2016-01-27 Bend Research, Inc Immediate release dosage forms containing solid drug dispersions
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
CA2524806C (en) * 2003-05-07 2011-07-12 Akina, Inc. Highly plastic granules for making fast melting tablets
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
US20070196474A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly disintegrating low friability tablets comprising calcium carbonate
US20070196477A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly dissolving tablets comprising low surface area calcium phosphates
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents

Also Published As

Publication number Publication date
BRPI0820861A2 (pt) 2015-06-16
KR20100096140A (ko) 2010-09-01
EP2231126A2 (en) 2010-09-29
RU2010128019A (ru) 2012-01-20
WO2009071219A3 (en) 2009-09-11
WO2009071219A2 (en) 2009-06-11
CN101888834A (zh) 2010-11-17
JP2011506279A (ja) 2011-03-03
JP2015038123A (ja) 2015-02-26
TW200938233A (en) 2009-09-16

Similar Documents

Publication Publication Date Title
MX2010005175A (es) Comprimido dispersable oral.
WO2008112124A3 (en) Orally administrable films
MX343358B (es) Tabletas de acetato de ulipristal.
MX2009003911A (es) Formulaciones de liberacion inmediata, mejoradas de topiramato.
UA91376C2 (ru) Рецептура с контролируемым высвобождением
AU2010308458A8 (en) Orally transformable tablets
MA30725B1 (fr) Administration d'inhibiteurs de la dipeptidyl peptidase
WO2006084164A8 (en) Gastric retention and controlled release delivery system
IL197574A0 (en) Pharmaceutical compositions
MX2010002735A (es) Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.
MX2007007885A (es) Composiciones farmaceuticas oralmente desintegrables con agentes de indicacion sensorial.
WO2010038237A3 (en) Compositions exhibiting delayed transit through the gastrointestinal tract
IL193252A0 (en) N-hydroxyacrylamide compounds
ECSP10010052A (es) Formulaciones galenicas de alisquireno y valsartan
BRPI0817275A2 (pt) Combinação farmacêutica de alisquireno e valsartana
PH12017502249A1 (en) Tofacitinib orally disintegrating tablets
TW200600098A (en) Solid orally ingestible formulations of tetrodotoxin
JO3239B1 (ar) تركيبات جالينية من مركبات عضوية
UA95274C2 (ru) Твердый фармацевтический препарат, содержащий ирбесартан, и способы его изготовления
TR200903548A1 (tr) Oral yolla dağılan emoksipin bileşimleri
TR200903293A1 (tr) Oral yolla dağılan olanzapin tablet.
ATE381325T1 (de) Deramciclan-fumarat tabletten
WO2011128914A3 (en) Extended release pharmaceutical compositions of pramipexole
WO2008014232A3 (en) Pharmaceutical formulations for the treatment of alzheimer's disease
WO2006116582A3 (en) Pharmaceutical compositions comprising a substituted benzimidazole, buffering agent and vitamin b12

Legal Events

Date Code Title Description
FA Abandonment or withdrawal